CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

OXGN's Income from Cont. Operations Growth by Quarter and Year

Mateon Therapeutics Inc's Income from Cont. Operations results by quarter and year




OXGN Income from Cont. Operations (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -3.78 -0.64 -3.88
III Quarter September - -0.99 -0.79 -3.96
II Quarter June 0.58 -1.19 -2.43 -3.10
I Quarter March -4.66 -0.68 -3.54 -3.64
FY   -4.08 -6.64 -7.40 -14.58



OXGN Income from Cont. Operations second quarter 2020 Y/Y Growth Comment
Mateon Therapeutics Inc in the second quarter achieved Income from Cont. Operations of $ 0.58 millions compare to loss from continued operations recorded in same quarter a year ago.

According to the results reported in the second quarter, Mateon Therapeutics Inc achieved the best Income from Cont. Operations growth in Biotechnology & Drugs industry. While Mateon Therapeutics Inc' s Income from Cont. Operations no change of % ranks overall at the positon no. 0 in the second quarter.




OXGN Income from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Mateon Therapeutics Inc's second quarter 2020 Income from Cont. Operations $ 0.58 millions OXGN's Income Statement
Mateon Therapeutics Inc's second quarter 2019 Income from Cont. Operations $ -1.19 millions Quarterly OXGN's Income Statement
New: More OXGN's historic Income from Cont. Operations Growth >>


OXGN Income from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Mateon Therapeutics Inc's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's II. Quarter Q/Q Income from Cont. Operations Comment
Improvement II. Quarter 2020where Mateon Therapeutics Inc published Income from Cont. Operations of $ 0.58 millions may be considered as a starting point of positive performance.Mateon Therapeutics Inc announced in the II. Quarter 2020 Income from Cont. Operations of $ 0.58 millions compare to loss from continued operations recorded in previos quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Income from Cont. Operations growth. While Mateon Therapeutics Inc's Income from Cont. Operations growth quarter on quarter, overall rank is 0.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #0
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OXGN's II. Quarter Q/Q Income from Cont. Operations Comment
This reversal of fortune II. Quarter 2020where Mateon Therapeutics Inc delivered Income from Cont. Operations of $ 0.58 millions should is starting point of positive results.Mateon Therapeutics Inc announced in the II. Quarter 2020 Income from Cont. Operations of $ 0.58 millions compare to loss from continued operations recorded in previos quarter.

Within Biotechnology & Drugs industry Mateon Therapeutics Inc achieved highest sequential Income from Cont. Operations growth. While Mateon Therapeutics Inc's Income from Cont. Operations growth quarter on quarter, overall rank is 0.


Mateon Therapeutics Inc's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
Cumulative Income from Cont. Operations 12 Months Ending $ -8.85 $ -10.62 $ -6.64 $ -3.50 $ -3.30
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Mateon Therapeutics Inc' has realized cumulative trailing twelve months loss from continued operations of $ -9 millions in the Jun 30 2020 period.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Mateon Therapeutics Inc' has realized cumulative trailing twelve months loss from continued operations of $ -9 millions in the Jun 30 2020 period.

Mateon Therapeutics Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Biotechnology & Drugs Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
OXGN's Income from Cont. Operations Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for OXGN's Competitors
Income from Cont. Operations Growth for Mateon Therapeutics Inc's Suppliers
Income from Cont. Operations Growth for OXGN's Customers

You may also want to know
OXGN's Annual Growth Rates OXGN's Profitability Ratios OXGN's Asset Turnover Ratio OXGN's Dividend Growth
OXGN's Roe OXGN's Valuation Ratios OXGN's Financial Strength Ratios OXGN's Dividend Payout Ratio
OXGN's Roa OXGN's Inventory Turnover Ratio OXGN's Growth Rates OXGN's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Jun 30 2020 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Jun 30 2020
Mettler Toledo International Inc -0.47 %$ -0.470 millions
Lifevantage Corp -5.22 %$ -5.221 millions
Msa Safety Inc -9.24 %$ -9.239 millions
Catalyst Pharmaceuticals Inc -10.77 %$ -10.766 millions
Atrion Corporation -10.96 %$ -10.958 millions
Quest Diagnostics Inc -11.87 %$ -11.872 millions
Medpace Holdings inc -12.21 %$ -12.205 millions
Acadia Healthcare Company Inc -13.46 %$ -13.458 millions
Icu Medical Inc -17.19 %$ -17.190 millions
Amgen Inc -17.26 %$ -17.256 millions
Lemaitre Vascular Inc -24.31 %$ -24.308 millions
Vanda Pharmaceuticals Inc -24.40 %$ -24.397 millions
U S Physical Therapy Inc -25.44 %$ -25.439 millions
Neurotrope inc -26.83 %$ -26.833 millions
Baxter International Inc -27.99 %$ -27.988 millions
Five Star Senior Living Inc -28.20 %$ -28.199 millions
Pfizer Inc -32.08 %$ -32.081 millions
Bruker Corporation -34.59 %$ -34.595 millions
Johnson and Johnson -35.33 %$ -35.331 millions
Phibro Animal Health Corp -35.90 %$ -35.901 millions
Becton Dickinson And Company -36.59 %$ -36.585 millions
Abbott Laboratories -46.62 %$ -46.620 millions
United Therapeutics Corporation -47.78 %$ -47.782 millions
Abiomed Inc -49.86 %$ -49.858 millions
Encompass Health Corporation -56.58 %$ -56.577 millions
Pacific Health Care Organization Inc -57.14 %$ -57.142 millions
Semler Scientific Inc -58.95 %$ -58.954 millions
Utah Medical Products Inc -62.75 %$ -62.752 millions
Jrsis Health Care Corp -63.70 %$ -63.700 millions
Syneos Health Inc -65.36 %$ -65.365 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ENSV's Profile

Stock Price

ENSV's Financials

Business Description

Fundamentals

Charts & Quotes

ENSV's News

Suppliers

ENSV's Competitors

Customers & Markets

Economic Indicators

ENSV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071